What it's sold for
- Metabolic health
- Endurance & performance
- Longevity
What has actually been tested
- Aminoglycoside Toxicity
- Bilateral Vestibular Deficiency
- Bilateral Vestibular Hypofunction
- Bilateral Vestibulopathy
- Breast Cancer
- Chronic Kidney Disease
- Gentamicin Ototoxicity
- Insulin Resistance
Is it studied for what it's sold for?
Each claim below is matched against the condition and title fields of every registered trial. Not listed means no trial names it as a studied condition — not that it has been disproven, and not that no trial touches it indirectly.
Every trial on record
Every registered human study we can find for MOTS-c. Click any ID to read the original record — we would rather you checked us than trusted us.
| Trial ID | Title | Condition | Phase | Status | Enrolled |
|---|---|---|---|---|---|
| NCT07438002 | Analysis of Effects of High-intensity Physical Exercise in Subjects With Dialyzed Chronic Kidney Disease and in Conservative Treatment | Chronic Kidney Disease | Not phased | Recruiting now | 50 |
| NCT06500975 | Long Term Outcomes After Vestibular Implantation | Bilateral Vestibular Hypofunction, Bilateral Vestibular Deficiency | Not phased | Recruiting now | 32 |
| NCT07505745 | MOTS-c for Improving Insulin Sensitivity in Adults With Prediabetes and Overweight/Obesity | Prediabetes, Insulin Resistance | Phase 2 | Recruiting now | 120 |
| NCT07678073 | Comparison of the Effects of General Anesthesia and Combined Spinal-Epidural Anesthesia on Ferroptosis, Humanin and MOTS-c Levels in Renal Transplantation | Kidney Disease, End-Stage, Kidney Transplant | Not phased | Recruiting now | 68 |
| NCT04013568 | Exercise Post-Diagnosis of Breast Cancer | Breast Cancer | Not phased | Completed | 62 |
Common questions about MOTS-c
How many human trials does MOTS-c have?
5. That is the number of registered interventional human studies we can find, each listed on this page with a link to its original record.
Is MOTS-c FDA approved?
No. MOTS-c is not approved by the FDA for any indication. Compounded or "research use only" preparations are not FDA-approved and receive no premarket review for safety, effectiveness, or manufacturing quality.
What is MOTS-c actually being tested for?
Registered studies cover: chronic kidney disease, bilateral vestibular hypofunction, bilateral vestibular deficiency. Compare that to what it is marketed for — the two lists are often different, which is the whole point of this page.
Where does this data come from?
ClinicalTrials.gov, the US public registry of clinical studies. We count interventional human studies only — observational studies are not evidence of effect. Every trial on this page links to its original record so you can check us rather than trust us.
Get told when this changes
One email a week: what moved in the research, and which claims the record doesn't support. Free, and you can leave in one click.